Method for identification of T-cell epitopes and use for preparing molecules with reeduced immunogenicity
Details for Australian Patent Application No. 2002256624 (hide)
International Classifications
Event Publications
6 March 2003 Application Open to Public Inspection
Published as AU-B-2002256624
6 December 2007 Application Accepted
Published as AU-B-2002256624
24 January 2008 Corrigenda
Applications Accepted - Name Index Under the name Merck Patent GmbH, Application No. 2002256624, under INID (54), correct the invention title to read Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity
3 April 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002256625-METHOD AND SYSTEM FOR MULTIPLE HOSTS ANYCAST ROUTING
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser